Cargando…

Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic Kras(G12D) in pancreatic cancer

CRISPR/Cas9 is a promising technology for gene editing. To date, intracellular delivery vehicles for CRISPR/Cas9 are limited by issues of immunogenicity, restricted packaging capacity, and low tolerance. Here, we report an alternative, nonviral delivery system for CRISPR/Cas9 based on engineered exo...

Descripción completa

Detalles Bibliográficos
Autores principales:	McAndrews, Kathleen M, Xiao, Fei, Chronopoulos, Antonios, LeBleu, Valerie S, Kugeratski, Fernanda G, Kalluri, Raghu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Life Science Alliance LLC 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321670/ https://www.ncbi.nlm.nih.gov/pubmed/34282051 http://dx.doi.org/10.26508/lsa.202000875

Ejemplares similares

Exosomes Facilitate Therapeutic Targeting of Oncogenic Kras in Pancreatic Cancer
por: Kamerkar, Sushrut, et al.
Publicado: (2017)

Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity
por: McAndrews, Kathleen M., et al.
Publicado: (2021)

A peek into cancer-associated fibroblasts: origins, functions and translational impact
por: LeBleu, Valerie S., et al.
Publicado: (2018)

Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses
por: Hensel, Janine, et al.
Publicado: (2020)

Engineered immunomodulatory extracellular vesicles derived from epithelial cells acquire capacity for positive and negative T cell co-stimulation in cancer and autoimmunity
por: Kugeratski, Fernanda G., et al.
Publicado: (2023)

Mechanisms associated with biogenesis of exosomes in cancer
por: McAndrews, Kathleen M., et al.
Publicado: (2019)

Emerging role of bacterial extracellular vesicles in cancer
por: Chronopoulos, Antonios, et al.
Publicado: (2020)

Dual reporter genetic mouse models of pancreatic cancer identify an epithelial‐to‐mesenchymal transition‐independent metastasis program
por: Chen, Yang, et al.
Publicado: (2018)

Unique somatic variants in DNA from urine exosomes of individuals with bladder cancer
por: Zhou, Xunian, et al.
Publicado: (2021)

4078 Identification of distinct fibroblast populations with unique roles in pancreatic cancer progression and tumor immunity
por: Darpolor, Josephine Kebbeh, et al.
Publicado: (2020)

EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer
por: Zheng, Xiaofeng, et al.
Publicado: (2015)

Selective targeting of the oncogenic KRAS G12S mutant allele by CRISPR/Cas9 induces efficient tumor regression
por: Gao, Qianqian, et al.
Publicado: (2020)

Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
por: Carstens, Julienne L., et al.
Publicado: (2017)

Selective targeting of KRAS oncogenic alleles by CRISPR/Cas9 inhibits proliferation of cancer cells
por: Lee, Wookjae, et al.
Publicado: (2018)

Podoplanin(+) tumor lymphatics are rate limiting for breast cancer metastasis
por: Chen, Yang, et al.
Publicado: (2018)

Enacting national social distancing policies corresponds with dramatic reduction in COVID19 infection rates
por: McGrail, Daniel J., et al.
Publicado: (2020)

CRISPR prime editing for unconstrained correction of oncogenic KRAS variants
por: Jang, Gayoung, et al.
Publicado: (2023)

Precise and efficient silencing of mutant Kras(G12D) by CRISPR-CasRx controls pancreatic cancer progression
por: Jiang, Wang, et al.
Publicado: (2020)

CRISPR/Cas9-Mediated Knock-Out of Kras(G12D) Mutated Pancreatic Cancer Cell Lines
por: Lentsch, Eva, et al.
Publicado: (2019)

Type-I collagen produced by distinct fibroblast lineages reveals specific function during embryogenesis and Osteogenesis Imperfecta
por: Chen, Yang, et al.
Publicado: (2021)

Targeting mutant KRAS with CRISPR-Cas9 controls tumor growth
por: Kim, Wonjoo, et al.
Publicado: (2018)

Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity
por: McAndrews, Kathleen M., et al.
Publicado: (2020)

Biology and therapeutic potential of mesenchymal stem cell‐derived exosomes
por: Xunian, Zhou, et al.
Publicado: (2020)

Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014)

Efficient Correction of Oncogenic KRAS and TP53 Mutations through CRISPR Base Editing
por: Sayed, Shady, et al.
Publicado: (2022)

Activin–like kinase–3 activity is important for kidney regeneration and reversal of fibrosis
por: Sugimoto, Hikaru, et al.
Publicado: (2012)

The emerging roles of exosomes in the modulation of immune responses in cancer
por: Kurywchak, Paul, et al.
Publicado: (2018)

PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation to promote metastasis
por: LeBleu, Valerie S., et al.
Publicado: (2014)

In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
por: Maddalo, Danilo, et al.
Publicado: (2014)

Epithelial to Mesenchymal Transition induces cell cycle arrest and parenchymal damage in renal fibrosis
por: Lovisa, Sara, et al.
Publicado: (2015)

CRISPR-Cas9/Cas12a biotechnology and application in bacteria
por: Yao, Ruilian, et al.
Publicado: (2018)

Targeted Degradation of Oncogenic KRAS(G12C) by VHL-Recruiting PROTACs
por: Bond, Michael J., et al.
Publicado: (2020)

Oncogenic KRAS G12C: Kinetic and redox characterization of covalent inhibition
por: Huynh, Minh V., et al.
Publicado: (2022)

High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis
por: Xu, Xingbo, et al.
Publicado: (2018)

CaSilico: A versatile CRISPR package for in silico CRISPR RNA designing for Cas12, Cas13, and Cas14
por: Asadbeigi, Adnan, et al.
Publicado: (2022)

Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer
por: Carstens, Julienne L., et al.
Publicado: (2021)

Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice
por: Collins, Meredith A., et al.
Publicado: (2012)

Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity
por: Luo, Yongde, et al.
Publicado: (2021)

Pancreatitis promotes oncogenic Kras(G12D)-induced pancreatic transformation through activation of Nupr1
por: Grasso, Daniel, et al.
Publicado: (2014)

Diagnostics of Infections Produced by the Plant Viruses TMV, TEV, and PVX with CRISPR-Cas12 and CRISPR-Cas13
por: Marqués, María-Carmen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vfonbe0vqkvjg9j97n9fucfj1e